Monday, November 25, 2024
HomeTagsSanofi

Sanofi

Vir and Sanofi Partner for T-Cell Engager License

Vir Biotechnology, Inc, announced that it has entered into an exclusive worldwide license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and...

Medidata and Sanofi Vaccines expand collaboration to improve patient-centricity and clinical trial efficiency

Medidata, a Dassault Systèmes company and a leading provider of clinical trial solutions for the life sciences industry, and Sanofi Vaccines are leveraging Medidata eCOA to We...

Sanofi and Teva Announce Exclusive Collaboration to Deliver Inflammatory Bowel Disease Treatment

Sanofi and Teva Pharmaceuticals, a U.S. subsidiary of Teva Pharmaceutical Industries Ltd.  announce a collaboration to co-develop and co-commercialize asset TEV ‘574, currently in...

Rona Therapeutics Announces Exclusive Licensing Transaction from Sanofi

Rona Therapeutics, Inc ("Rona"), a fully integrated platform company dedicated to the discovery, development and manufacturing of RNA therapeutics, announced that it has obtained...

FDA Accepts Dupixent for Priority Review in Patients Aged 12 Years and Older with Eosinophilic Esophagitis

Regeneron Pharmaceuticals, Inc. and Sanofi announced the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA)...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics